MicroStrategy, now called Strategy, has temporarily halted its Bitcoin purchases just before its Q1 2026 earnings report on May 5. This pause follows a volatile quarter where Bitcoin's price dropped over 20%, despite the company buying about 89,600 BTC worth $5.5 billion in Q1. Strategy currently holds 818,334 BTC valued at around $64.44 billion but faces a modest unrealized gain due to the price drop. Investors await the earnings report, expecting revenue of $120 million but a GAAP loss driven by Bitcoin's market value decline, while the company shifts funding from common stock to preferred shares offering an 11.5% dividend.
Prestige Consumer Healthcare completed the acquisition of Australian therapeutic skin care company LaCorium Health for approximately $150 million in cash on July 1, 2026. LaCorium, known for brands like Dermal Therapy and Flexitol, generates about $4...
GuideAI Health Corp. has appointed Dr. James F. Benenati, a leading interventional radiologist, to its Advisory Board following FDA 510(k) clearance of its AI software, VascularAssist Occlusion Triage (VAOT). VAOT is designed to help radiologists pri...
Diginex Limited has agreed with Resulticks to extend the deadline for their acquisition deal to July 31, 2026, after securing firm funding intent from private investors. The company does not plan to seek public funding and expects this to be the fina...
Rogers Communications has agreed to buy the remaining 25% stake in Maple Leaf Sports & Entertainment (MLSE) from Kilmer Sports for C$4.35 billion, making Rogers the sole owner. This move aims to strengthen Rogers' position in Canadian sports and ente...
VERAXA Biotech updated on its progress in developing novel cancer therapies using its proprietary BiTAC platform, focusing on conditionally active T cell engagers and bispecific antibody-drug conjugates. The company plans to prioritize investment in ...
